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Quantitative estimates of cerebral metabolic rate of oxygen utilization using magnetic resonance
imaging can have profound implications for the understanding of brain metabolic activity as well
as the investigation of cerebrovascular disease. In this study, five normal volunteers were studied.
All images were acquired on a Siemens 1.5 T scanner (Siemens Medical Systems Inc, Erlangen,
Germany). Cerebral blood flow (CBF) was obtained in vivo with a dynamic imaging approach and
the acquired images were post-processed with the singular value decomposition method (SVD). In
addition, a multi-echo gradient echo/spin echo sequence was employed to provide MR estimates
of oxygen extraction fraction (MR_OEF) in vivo. Subsequently, an absolute measure of MR
cerebral metabolic rate of oxygen utilization (MR_CMRO2) was obtained in all subjects by taking
the product of CBF and MR_OEF. A mean MR_CMRO2 of 28.94 ± 3.26 ml/min/100 g and 12.57
± 3.11 ml/min/100 g was obtained for gray matter and white matter, respectively, suggesting that
the gray matter utilizes more oxygen than white matter under normal physiological conditions.
These results yield a gray matter to white matter CMRO2 ratio of 2.37 ± 0.37, which is
comparable to the reported values in the literature. More studies are needed to further improve on
the accuracy as well as shortening the required data acquisition time so that the proposed
approaches can be utilized in a routine clinical setting.
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INTRODUCTION
When brain tissue is under an ischemic insult resulting from a reduction of cerebral blood
flow (CBF), an increase in oxygen extraction fraction (OEF) normally occurs to maintain
normal neuronal function. Despite the compromised CBF, the ischemic tissues can
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potentially remain viable for a long period of time as long as OEF does not reach its
maximum available level. Conversely, when the maximum OEF is reached, the inability to
maintain normal neuronal function can trigger a cascade of cellular events, which could
eventually lead to cell death. Therefore, while CBF is a good indicator for oxygen delivery,
CBF by itself does not precisely determine tissue viability. It has been suggested that the
balance between oxygen delivery and oxygen demand can more accurately depict tissue
viability under ischemic insults.1 Therefore, the ability to obtain quantitative estimates of
cerebral metabolic rate of oxygen utilization (CMRO2), which is usually defined as the
product of cerebral blood flow, oxygen extraction fraction and arterial oxygen content, can
be of critical importance for the investigation of cerebrovascular disorders.
To date, positron emission tomography (PET) has been the method of choice for obtaining
in vivo measurements of CMRO2. With a quantitative estimate of CBF and OEF, an absolute
measure of CMRO2 can be obtained in vivo.2 However, PET requires radioactive isotopes, is
invasive, is physician-intensive, and has certain risks. Furthermore, the required onsite
cyclotron for obtaining quantitative measures of CMRO2 has limited its accessibility to
major medical centers. Therefore, there is an increasing need to develop a non-invasive
imaging method that is able to provide similar physiological parameters as those available
via PET in a ubiquitous imaging modality such as magnetic resonance (MR) imaging.
In light of recent advances in MR imaging, it is now possible to not only obtain anatomical
information but also to provide physiological parameters with MRI. Specifically, many
investigators have demonstrated that changes of blood oxygen saturation cause alterations of
T2* and/or T2 in tissue and thus MR signal intensity.3,4 This phenomenon, blood oxygen
level dependent (BOLD) contrast, has been widely utilized for the investigation of brain
activation during an external sensory and/or cognitive input.5,6 Intriguing results have been
reported, demonstrating its ability to reveal how the brain works. Nevertheless, the extent of
signal changes in BOLD contrast is multi-factorial and affected by many physiological
parameters such as CBF, cerebral blood volume (CBV), hematocrit, etc. Therefore,
approaches to provide a quantitative estimate of blood oxygen saturation in vivo are highly
desirable. With a signal model proposed by Yablonskiy and Haacke7 characterizing signal
dephasing induced by the presence of deoxyhemoglobin, we have recently demonstrated that
quantitative estimates of cerebral blood oxygen saturation can be obtained in vivo,8 which in
turn can provide a measure of OEF with MRI (MR_OEF). However, an absolute measure of
CMRO2 using MR is still lacking. In this paper, we will demonstrate that CBF and OEF
measurements can be obtained with a dynamic approach and through the BOLD effects,




Five normal healthy subjects were recruited for this study and written informed consent was
obtained from all subjects. All images were acquired on a 1.5 T Vision whole body scanner
(Siemens Medical Inc., Erlangen, Germany) with a maximum gradient strength of 25 mT/m
and a ramp time of 0.6 ms. A standard circularly polarized head coil was used as the
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transmit/receive coil. A system shimming was carefully employed prior to the imaging
experiments. A two-dimensional multi-echo gradient echo/spin echo sequence (Fig. 1) was
used to acquire images, which were subsequently used to extract R2, R2′, cerebral venous
blood volume (λ) and MR_OEF.8 In total, 21 echoes with TEs ranging from 62.6 to 161.8
ms were acquired. All acquired echoes were odd echoes so that signal from flowing spins
such as blood could be minimized. The echo spacing between two adjacent echoes was 4.96
ms. The spin echo occurred at the eleventh echo with TE = 112.2 ms and 10 gradient echoes
were acquired symmetrically on each side of the spin echo. The imaging parameters were as
follows: TR = 1 s; field-of-view (FOV) = 160 × 256 mm2; a matrix size of 80 × 128
resulting in an inplane resolution of 2 × 2 mm2; slice thickness (TH) = 8 mm; three slices
with a gap of 4 mm; and eight acquisitions to improve the signal-to-noise ratio. The total
data acquisition time was 10 min and 40 s. In addition, a two-dimensional single-shot
gradient echo echo-planar imaging (EPI) sequence was used to obtain CBF and CBV maps.
The imaging parameters were as follows: TR = 2 s; TE = 54 ms; TH = 6 mm; in-plane
resolution = 1.8 × 1.1 mm2; and FA = 60°. This sequence was repeated 40 times while the
subjects were lying still inside the MR scanner. Contrast agent (0.1 mmol/kg, Gd-DTPA)
was administered intravenously at the completion of the fifth scan.
MR_OEF estimates
In order to obtain quantitative estimates of MR_OEF, images acquired by the multi-echo
gradient echo/spin echo sequence were employed. The images were first collapsed to a
matrix size of 64 × 64 prior to any data processing in order to improve signal-to-noise.
Detailed descriptions as to how an absolute measure of cerebral venous blood oxygen
saturation can be obtained have been given elsewhere.8 Only a short description is given
below.
With the theoretical model proposed by Yablonskiy and Haacke7 to characterize MR signal
dephasing phenomena in the static dephasing regime, a relationship between R2′ and
fractional cerebral venous blood oxygen saturation (CBOS) is given as follows:7
(1)
where γ is the gyromagnetic ratio, which is equal to 2.68 × 108 rad/s/T; Hct is the fractional
hematocrit; B0 is the static magnetic field strength; and Δχ0 is the susceptibility difference
between fully oxygenated and fully deoxygenated blood which has been measured to be
0.18 ppm per unit Hct.9 In addition, R2′ ( , where  and R2 = 1/T2) is the
relaxation rate, which is commonly employed to characterize the effects of local
susceptibilities and λ is the venous blood volume fraction. Both R2′ and λ can be estimated
from the images acquired by the multi-echo gradient echo/spin echo sequence (please see
Ref. 8 for details). In order to obtain cerebral blood oxygen saturation, Hct in eqn (1) was
replaced by cerebral Hct (cHct). This was done by assuming that the ratio between small
vessel to large vessel Hct is 0.85. Finally, assuming the arterial blood is fully oxygenated,
the cerebral oxygen extraction fraction (MR_OEF) can then be calculated as
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Measurements of cerebral hemodynamics and correction of large vessel effects
The images acquired by the two-dimensional single-shot EPI sequence were first converted
to the ΔR2* maps. Subsequently, an arterial input function was chosen from the M1 section
of the middle cerebral artery for each subject. A least squares exponential fitting was
employed to minimize the secondary circulation. Finally, singular value decomposition
(SVD) deconvolution as proposed by Ostergaard et al.10,11 was employed to obtain
estimates of cerebral hemodynamics including CBF, CBV, and mean transit time.
In our study, a gradient echo EPI sequence was utilized to obtain quantitative estimates of
CBF. The increased sensitivity to large vessels with a gradient echo EPI sequence may lead
to an overestimation of CBF when compared to a spin echo EPI sequence.12,13 Therefore, it
is of critical importance to minimize the effects of large vessels in MR-measured CBF prior
to the final calculation of MR_CMRO2. A simple thresholding method utilizing CBV maps
was employed to minimize the effects of large vessels in the CBF maps. A normalized CBV
histogram was first obtained from all five volunteers. As shown in Fig. 2, the majority of
CBV is less than 10%. Thus, a Gaussian curve fit was applied to the histogram within this
range. A CBV threshold of 6.8% was then chosen based on the full width half maximum
(FWHM). Subsequently, for pixels that had CBV values greater than the experimentally
derived CBV threshold, the corresponding pixels in the CBF maps were set to zero. A
closing operation, in which only nonzero neighboring pixels were averaged to yield the
replacing value, was carried out to remove the holes caused by the thresholding processes.
In addition, a low-pass filter was employed for CBF maps to achieve the same spatial
resolution as that in MR_OEF maps. Finally, a co-registration process between MR_OEF
and CBF was performed and MR_CMRO2 maps were then obtained as:
(3)
A region-of-interest (ROI) analysis was performed to obtain regional measurements of
MR_CMRO2. Four ROIs, one in the cortical gray matter and one in the subcortical white
matter regions of each hemisphere, were defined.
RESULTS
Plate 1 demonstrates the effects of large vessels in both CBV and CBF maps. Prominent
CBV (>7%) is observed at the cortical sulci, which coincides with the elevated CBF prior to
the application of CBV threshold. In contrast, substantial reductions in both CBV as well as
CBF are observed, particularly at the cortical sulci when the experimentally defined CBV
threshold is employed, minimizing the effects of large vessels on both the CBF and CBV
maps. Quantitative estimates of CBF for all subjects are summarized in Table 1. The group
mean and inter-subject variability of CBF are 67.51 ± 10.53 ml/min/100 g and 33.89 ± 5.11
ml/min/100 g for the gray matter and white matter, respectively, in good agreement with
those reported in the literature.14
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Representative examples of MR estimated CBF, MR_OEF, and MR_CMRO2 are shown in
Plate 2. A rather uniform OEF, on the order of 40%, across both hemispheres is observed,
suggesting that the brain extracts a similar amount of oxygen in both gray and white matter.
In contrast, a clear demarcation between gray and white matter in the MR_CMRO2 map is
observed, with gray matter exhibiting higher CMRO2 values than those in white matter.
Finally, regional measurements of MR_OEF and MR_CMRO2 are summarized in Tables 2
and 3 for all subjects, respectively. The group mean and inter-subject variability of
MR_OEF is 39.9 ± 2.7% for the whole brain. ROI GML and ROI GMR represent
MR_CMRO2 measurements obtained from ROIs defined in the gray matter while ROI
WML and ROI WMR summarize MR_CMRO2 measurements of the white matter in both
the left and right hemispheres, respectively. Notice the MR_CMRO2 is symmetric for both
hemispheres in all subjects. The group mean and inter-subject variability of MR_CMRO2
are 28.9 ± 3.3 ml/min/100 g and 12.6 ± 3.1 ml/min/100 g for gray matter and white matter,
respectively, yielding a gray matter to white matter CMRO2 ratio (GMcmro2/WMcmro2) of
2.37 ± 0.37. The group mean and inter-subject variability of MR_CMRO2 for the whole
brain is 20.8 ± 3.2 ml/min/100 g.
DISCUSSION
In order to obtain quantitative estimates of CMRO2, two physiological parameters, namely
CBF and OEF, are required. With a dynamic imaging approach and post-processed using the
SVD method as proposed by Ostergaard et al., quantitative estimates of CBF are obtained in
normal volunteers. The group mean and inter-subject variability of CBF are 67.5 ± 10.5
ml/min/100 g and 33.9 ± 5.1 ml/min/100 g in the gray matter and white matter, respectively,
in excellent agreement with the reported values in the literature.14 In addition, a multi-echo
gradient echo/spin echo sequence is employed to obtain absolute measures of MR_OEF.
Assuming that the arterial blood is fully saturated, a reasonable assumption for the normal
healthy subjects or patients without pulmonary diseases, our results suggest that cerebral
venous blood oxygen saturation is on the order of 60%. This finding is in excellent
agreement with our previously reported results8 in normal volunteers, demonstrating the
consistency of the proposed approach for obtaining MR_OEF. After obtaining both
physiological parameters independently, an absolute measure of MR_CMRO2 can be
obtained by multiplying the CBF with MR_OEF.
As shown in Plate 2, the MR_CMRO2 map reveals a clear contrast between gray matter and
white matter with gray matter having a higher CMRO2 value than that of white matter. A
GMcmro2/WMcmro2 ratio of 2.37 ± 0.37 is obtained from our study. With PET and an
oxygen-15 steady-state inhalation technique, Lammertsma et al.14 measured CMRO2 and
OEF in normal subjects and brain tumour and stroke patients. They reported a GMcmro2/
WMcmro2 ratio of 1.97 in normal subjects, which is slightly lower than that obtained from
our studies. When examining their results closely, our results exhibit a higher CBF,
particularly in the gray matter (67.5 ± 10.5 ml/min/100 g in our study vs 59 ± 8 ml/min/100
g in Lammertsma et al.’s PET study), leading to a higher CMRO2 in gray matter and hence
the elevated GMcmro2/WMcmro2 ratio. The observed higher CBF based on MR studies is
perhaps not surprising. With the improved spatial resolution, the partial volume effects are
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likely to be minimized in MR images. Therefore, a higher CBF value is commonly seen with
MR approaches when compared to that obtained using PET. Nevertheless, the GMcmro2/
WMcmro2 ratio obtained from our studies still compares favorably with that reported in the
literature.
Since a quantitative estimate of MR_CMRO2 is obtained with the proposed approach, it is
necessary to assess the accuracy of the MR measured CMRO2 with that reported in the
literature. One of the major discrepancies between MR measured CMRO2 and that obtained
via PET is the effects of arterial oxygen content. MR_CRMO2 is computed by simply taking
the product of CBF and OEF vs the product of CBF, OEF and arterial oxygen content
(CaO2) as normally been done in PET. Therefore, in order to compare our experimental
results to those obtained from other modalities, such as PET, CaO2 is needed. Under normal
physiological conditions, CaO2 ranges between 16 and 20 ml O2/100 ml blood. Therefore,
the MR measured CMRO2 ranges between 4.4 and 5.5 ml/100 g/min for gray matter and
2.16–2.70 for white matter with the normal CaO2, respectively. With PET and normal
volunteers, Ishii et al. demonstrated that the normal regional CMRO2 ranged between 3.40
and 4.36 ml/100 g/min at different cortical areas.15 In addition, with a global assessment of
CMRO2 using PET, Leblanc reported that the whole brain CMRO2 ranged between 3.29–
3.45 ml/100 g/min,16 vs our whole brain CMRO2 range, 3.29–4.12 ml/100 g/min. Clearly,
our estimates of CMRO2 are slightly higher than that obtained by PET. There are two
potential explanations for the observed higher MR_CMRO2. First, as mentioned previously,
the MR measured CBF appears to be higher than that obtained via PET, presumably due to
the improved spatial resolution and thus minimizing partial volume effects. As a result, a
higher CMRO2 is anticipated with the MR approach. Second, while a threshold approach
based on a CBV histogram is employed to minimize the effects of large vessels in the
estimates of CBF, some residual large vessel effects may still be present. Under normal
physiological conditions, CBV is known to be within 3–5% and 2–3% for gray and white
matter, respectively. However, the partial volume effect from large vessels causes an
elevated CBV in some cortical areas, seen as the tail on the right side of CBV histogram in
Fig. 2. The CBV distribution in gray matter and white matter can each be represented by a
Gaussian curve. Ideally, by excluding the CBV in the region which has large vessel effect,
the distribution of CBV for the whole brain can be approximated by the sum of two
Gaussian curves from gray and white matter. Since the mean of CBV from gray and white
matter are comparable and partial volume effect exists between the two tissues, a single
Gaussian curve can be utilized to approximate the CBV distribution for the whole brain.
This Gaussian curve is expected to have a mean roughly at 3.3% and a standard deviation of
1.5–2.0% based on the normal physiological range of CBV. Therefore, the upper limit of
CBV without large vessel effect for the whole brain can be roughly calculated as mean +3
standard deviations, which yields a range of 8–10%. In this study, a Gaussian curve fit was
performed on the CBV histogram ranging from 0 to 10% in an attempt to minimize the
effects of large vessels. The mean and standard deviation of the fitted Gaussian curve are
3.28 and 3.01%, respectively. Therefore, a CBV threshold of 6.8% is then determined based
on the FWHM of the fitted Gaussian curve. As shown in Plate 1, the application of the CBV
threshold successfully removes some of the large vessels in different cortical areas.
Nevertheless, similar to other thresholding based approaches in general, the predefined CBV
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threshold can work to some extent but might not be able to remove all the large vessel
effects, causing a potential elevation in the measures of CBF. Alternatively, a SE EPI
sequence, which has been suggested as having minimal effects from large vessels,12,13 can
be employed to obtain estimates of CBF. However, the compromised signal-to-noise ratio in
the estimates of CBF with SE EPI sequences has prevented us from utilizing this approach.
Although more studies will be needed to further investigate the effects of large vessels in the
estimates of MR_CMRO2, our preliminary results demonstrate that quantitative measures of
MR_CMRO2 can be obtained in vivo and results are within the physiological range as
reported via PET.
The approach for obtaining quantitative estimates of MR_OEF using a multi-echo gradient
echo/spin echo deserves further discussion. We have previously demonstrated that a
quantitative estimate of cerebral blood oxygen saturation can be obtained with this
approach.8 In eight healthy volunteers, a mean cerebral blood oxygen saturation of 58.7 ±
1.8% was obtained, indicating a MR_OEF of 41.3%. Consistent with our previously
reported results, a mean MR_OEF of 39.9 ± 2.7% was obtained from all subjects. While
these results are in good agreement with the results reported using different modalities such
as PET, several potential confounding factors inherent in the estimates of MR_OEF can
impose errors on the estimates of MR_CMRO2. Discussions as to how different
confounding factors might affect the accuracy of MR_OEF estimates have been addressed in
great detail in Ref. 8, only a brief discussion is given below for each potential confounding
factor. First, the signal model proposed by Yablonskiy and Haacke assumes that there are no
diffusion effects as well as no signal contributions from the blood.7 Given the normal ranges
of CBV as well as the field strength employed in our study, these two assumptions are likely
to be reasonable and should not impose substantial errors in the estimates of in vivo
MR_CMRO2.
Second, in order to quantify cerebral blood oxygen saturation, a prior knowledge of Hct is
required when both R2′ and λ are known [eqn (1)]. However, a direct measurement of Hct
from each volunteer is not done owing to the fact that the Hct has been known to be stable in
humans. Hct in large vessel ranges between 0.4 and 0.45 depending on the genders.17
Therefore, a constant Hct of 0.42 is assumed in this study for all volunteers. However, in
order to estimate cerebral blood oxygen saturation via eqn (1), large vessel Hct needs to be
converted to the small vessel Hct. A wide range of the ratio of small vessel ‘cerebral Hct’
(cHct) to large vessel Hct (cHct/Hct = 0.62–0.92) has been reported by different
investigators in various species including humans.18–22 Despite the discrepancies in the
reported cHct/Hct ratios, PET has employed a general consensus of cHct/Hct = 0.85.23 In
our study, we adapted this cHct/Hct ratio from PET study in the estimate of CBOS/OEF.
Since a constant Hct is used in our study, errors may have occurred due to the potential
variation in Hct between subjects as well as the uncertainty in cHct/Hct ratio. However, the
errors induced by the former case can be easily overcome with a direct measurement of Hct
from each subject. On the other hand, the errors induced by the latter factor are likely to be
small under normal physiological conditions. How to obtain cHct/Hct accurately is beyond
the scope of this study.
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Third, we have previously demonstrated that the accuracy of MR_OEF is on the order of 9%
based on the imaging parameters, the field strength, and the postprocessing schemes
employed. The sources of error are likely to play a similar role in the estimates of
MR_CMRO2. Nevertheless, with recently available high field scanners such as 3 T systems,
the improved signal-to-noise ratio as well as sensitivity in detecting deoxyhemglobin
induced signal alterations should further improve the accuracy of the proposed methods.
CONCLUSION
Although it has been demonstrated that CMRO2 can be obtained with MR, it requires the
utilization of either 13C or 17O magnetic resonance spectroscopy (MRS).24–27 In addition to
the fact that radioactive isotopes are needed, the inability to provide spatially resolved
information as commonly associated with MRS has hampered the clinical utilities of these
approaches. We have demonstrated that quantitative estimates of CMRO2 can be obtained in
normal subjects based on BOLD contrast. While some confounding factors remain, our
results are in excellent agreement with those reported in the literature via PET. With the
detailed anatomical information available in MRI and the widely accessible MR scanners,
the ability to quantitatively estimate CMRO2 in vivo is likely to shed light on our
understanding of the pathophysiological aspects of cerebrovascular disease.
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Abbreviations used
BOLD blood oxygenation level-dependent
CaO2 arterial oxygen content
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CBF cerebral blood flow
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MR_OEF MR measured oxygen extraction fraction
MR_CMRO2 MR measured cerebral metabolic rate of oxygen
MRS magnetic resonance spectroscopy
OEF oxygen extraction fraction
PET positron emission tomography
SVD singular value decomposition
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Sequence diagram of the multi-echo gradient echo/spin echo sequence. GSS, GPE, and GRO
represent the slice select, phase encoding and frequency encoding, respectively. In addition,
ADC indicates where images are acquired
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The CBV histogram from all five volunteers (solid line), and the fitted Gaussian curve
(dashed line). Note that only CBV ranging from 0 to 20% are shown in this figure. The
frequency of CBV above 20% is negligible
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Representative CBV [Fig. 2(a)] and CBF [Fig. 2(c)] maps before and after removing the
large vessel effect [Fig. 2(b) and (d)]. The color bars represent absolute CBV in percent and
CBF in ml/100 g/min
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CBF [Fig. 3(a)], OEF [Fig. 3(b)] and CMRO2 [Fig. 3(c)] maps from one subject are shown.
The color bars represent the CBF in ml/100 g/min in (a), MR_OEF in percent in (b), and
MR_CMRO2 in ml/100 g/min in (c), respectively
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Table 1
ROI analysis of CBF (ml/100 g/min) on five volunteers
ROI GM ROI WM
1 75.9 ± 12.6 37.0 ± 8.6
2 73.0 ± 15.1 38.4 ± 10.9
3 72.4 ± 12.1 34.0 ± 10.4
4 49.7 ± 9.9 25.3 ± 9.4
5 66.7 ± 13.4 33.90 ± 12.2
Mean/SD 67.5 ± 10.5 33.90 ± 5.1
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Table 2
ROI analysis of OEF (%) on five volunteers
Whole brain
1 44.2 ± 5.0
2 40.2 ± 11.6
3 37.2 ± 5.7
4 39.5 ± 11.5
5 38.4 ± 7.6
Mean/SD 39.9 ± 2.7
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Table 3
ROI analysis of CMRO2 on five volunteers
ROI GML ROI GMR ROI WML ROI WMR
1 32.2 ± 5.5 32.1 ± 7.1 16.9 ± 5.9 19.0 ± 3.8
2 30.2 ± 7.7 30.1 ± 9.7 16.3 ± 4.2 17.1 ± 5.4
3 26.1 ± 5.5 27.3 ± 6.1 11.0 ± 4.3 13.4 ± 3.6
4 23.0 ± 7.3 22.0 ± 7.2 8.3 ± 4.1 9.7 ± 3.7
5 27.3 ± 5.6 26.3 ± 5.2 11.5 ± 5.2 11.9 ± 4.3
Mean/SD 27.8 ± 3.6 27.5 ± 3.9 12.8 ± 3.7 14.2 ± 3.8
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